Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

BATF-dependent IL-7RhiGM-CSF+ T cells control intestinal graft-versus-host disease
Evelyn Ullrich, … , Markus F. Neurath, Kai Hildner
Evelyn Ullrich, … , Markus F. Neurath, Kai Hildner
Published January 29, 2018
Citation Information: J Clin Invest. 2018;128(3):916-930. https://doi.org/10.1172/JCI89242.
View: Text | PDF
Research Article Gastroenterology Immunology Article has an altmetric score of 80

BATF-dependent IL-7RhiGM-CSF+ T cells control intestinal graft-versus-host disease

  • Text
  • PDF
Abstract

Acute graft-versus-host disease (GVHD) represents a severe, T cell–driven inflammatory complication following allogeneic hematopoietic cell transplantation (allo-HCT). GVHD often affects the intestine and is associated with a poor prognosis. Although frequently detectable, proinflammatory mechanisms exerted by intestinal tissue–infiltrating Th cell subsets remain to be fully elucidated. Here, we show that the Th17-defining transcription factor basic leucine zipper transcription factor ATF-like (BATF) was strongly regulated across human and mouse intestinal GVHD tissues. Studies in complete MHC-mismatched and minor histocompatibility–mismatched (miHA-mismatched) GVHD models revealed that BATF-expressing T cells were functionally indispensable for intestinal GVHD manifestation. Mechanistically, BATF controlled the formation of colon-infiltrating, IL-7 receptor–positive (IL-7R+), granulocyte-macrophage colony-stimulating factor–positive (GM-CSF+), donor T effector memory (Tem) cells. This T cell subset was sufficient to promote intestinal GVHD, while its occurrence was largely dependent on T cell–intrinsic BATF expression, required IL-7–IL-7R interaction, and was enhanced by GM-CSF. Thus, this study identifies BATF-dependent pathogenic GM-CSF+ effector T cells as critical promoters of intestinal inflammation in GVHD and hence putatively provides mechanistic insight into inflammatory processes previously assumed to be selectively Th17 driven.

Authors

Evelyn Ullrich, Benjamin Abendroth, Johanna Rothamer, Carina Huber, Maike Büttner-Herold, Vera Buchele, Tina Vogler, Thomas Longerich, Sebastian Zundler, Simon Völkl, Andreas Beilhack, Stefan Rose-John, Stefan Wirtz, Georg F. Weber, Sakhila Ghimire, Marina Kreutz, Ernst Holler, Andreas Mackensen, Markus F. Neurath, Kai Hildner

×

Total citations by year

Year: 2024 2023 2022 2021 2020 2019 2018 Total
Citations: 3 4 3 5 4 5 2 26
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (26)

Title and authors Publication Year
Tissue-infiltrating alloreactive T cells require Id3 to deflect PD-1-mediated immune suppression during GVHD.
Wang Y, He S, Calendo G, Bui T, Tian Y, Lee CY, Zhou Y, Zhao X, Abraham C, Mo W, Chen M, Sanders-Braggs R, Madzo J, Issa JP, Hexner EO, Wiest DL, Reshef R, Xue HH, Zhang Y
Blood 2024
Better clinical outcomes and lower triggering of inflammatory cytokines for allogeneic hematopoietic cell transplant recipients treated in home care versus hospital isolation - the Karolinska experience.
Ringdén O, Svahn BM, Moll G, Sadeghi B
Frontiers in immunology 2024
Multimodal analysis identifies microbiome changes linked to stem cell transplantation-associated diseases
Artacho A, González-Torres C, Gómez-Cebrián N, Moles-Poveda P, Pons J, Jiménez N, Casanova MJ, Montoro J, Balaguer A, Villalba M, Chorão P, Puchades-Carrasco L, Sanz J, Ubeda C
Microbiome 2024
Donor T cell STAT3 deficiency enables tissue PD-L1-dependent prevention of GVHD while preserving GVL activity
Qinjian Li, Xiaoqi Wang, Qingxiao Song, Shijie Yang, Xiwei Wu, Dongyun Yang, Isabelle J. Marié, Hanjun Qin, Moqian Zheng, Ubaydah Nasri, Xiaohui Kong, Bixin Wang, Elizabeth Lizhar, Kaniel Cassady, Josh Tompkins, David Levy, Paul Martin, Xi Zhang, Defu Zeng
Journal of Clinical Investigation 2023
Dissecting the regulatory network of transcription factors in T cell phenotype/functioning during GVHD and GVT
Harris R, Karimi M
Frontiers in immunology 2023
Novel T cell/organoid culture system allows ex vivo modeling of intestinal graft-versus-host disease
Matthe DM, Dinkel M, Schmid B, Vogler T, Neurath MF, Poeck H, Neufert C, Büttner-Herold M, Hildner K
Frontiers in immunology 2023
Interferon regulatory factor 4 plays a pivotal role in the development of aGVHD-associated colitis
Frueh JT, Campe J, Sunaga-Franze DY, Verheyden NA, Ghimire S, Meedt E, Haslinger D, Harenkamp S, Staudenraus D, Sauer S, Kreft A, Schubert R, Lohoff M, Krueger A, Bonig H, Chiocchetti AG, Zeiser R, Holler E, Ullrich E
OncoImmunology 2023
Single cell immune profiling reveals a developmentally distinct CD4+ GM-CSF+ T cell lineage that induces GI tract GVHD
C Piper, E Hainstock, C Yin-Yuan, Y Chen, A Khatun, M Kasmani, J Evans, JA Miller, J Gorski, W Cui, WR Drobyski
Blood Advances 2022
Dendritic cell-derived IL-27 p28 regulates T cell program in pathogenicity and alleviates acute graft-versus-host disease.
Gong H, Ma S, Chen J, Yang B, Liu S, Liu X, Han J, Wu X, Lei L, Yin Z, Sun H, Yu D, Liu H, Xu Y, Wu D
Signal Transduction and Targeted Therapy 2022
Ablation of Basic Leucine Zipper Transcription Factor ATF-Like Potentiates Estradiol to Induce Atopic Dermatitis
Zhang P, Liu L, Lai X, Chen R, Guo Y, JunjieMa, Chen W, Chen Z
Oxidative medicine and cellular longevity 2022
Graft-versus-host disease depletes plasmacytoid dendritic cell progenitors to impair tolerance induction
Yuanyuan Tian, Lijun Meng, Ying Wang, Bohan Li, Hongshuang Yu, Yan Zhou, Tien Bui, Alicia Li, Ciril Abraham, Yongping Zhang, Jian Wang, Chenchen Zhao, Shin Mineishi, Stefania Gallucci, David Porter, Elizabeth Hexner, Hong Zheng, Yanyun Zhang, Shaoyan Hu, Yi Zhang
Journal of Clinical Investigation 2021
Th17 Cell-Mediated Colitis Is Positively Regulated by Interferon Regulatory Factor 4 in a T Cell-Extrinsic Manner
V Buchele, P Konein, T Vogler, T Kunert, K Enderle, H Khan, M Büttner-Herold, CH Lehmann, L Amon, S Wirtz, D Dudziak, MF Neurath, C Neufert, K Hildner
Frontiers in immunology 2021
Mesenteric Lymph Node Transplantation in Mice to Study Immune Responses of the Gastrointestinal Tract
H Shaikh, JG Vargas, Z Mokhtari, KJ Jarick, M Ulbrich, JP Mosca, EA Viera, C Graf, DD Le, KG Heinze, M Büttner-Herold, A Rosenwald, J Pezoldt, J Huehn, A Beilhack
Frontiers in immunology 2021
Cytokine levels following allogeneic hematopoietic cell transplantation: a match-pair analysis of home care versus hospital care
O Ringdén, M Remberger, J Törlén, S Finnbogadottir, BM Svahn, B Sadeghi
International Journal of Hematology 2021
RUNX inhibitor suppresses graft-versus-host disease through targeting RUNX-NFATC2 axis.
Kubota H, Masuda T, Noura M, Furuichi K, Matsuo H, Hirata M, Kataoka TR, Hiramatsu H, Yasumi T, Nakahata T, Imai Y, Takita J, Adachi S, Sugiyama H, Kamikubo Y
2021
Granzyme A-producing T helper cells are critical for acute graft-versus-host disease.
Sungtae Park, Brad Griesenauer, Hua Jiang, Djamilatou Adom, Pegah Mehrpouya-Bahrami, Srishti Chakravorty, Majid Kazemian, Tanbeena Imam, Rajneesh Srivastava, Tristan A. Hayes, Julian Pardo, Sarath Chandra Janga, Sophie Paczesny, Mark H. Kaplan, Matthew R. Olson
JCI Insight 2020
Pathogenic Bhlhe40+ GM-CSF+ CD4+ T cells promote indirect alloantigen presentation in the GI tract during GVHD
C Piper, V Zhou, R Komorowski, A Szabo, B Vincent, J Serody, ML Alegre, BT Edelson, R Taneja, WR Drobyski
Blood 2020
Transcription Factor Bhlhe40 in Immunity and Autoimmunity
ME Cook, NN Jarjour, CC Lin, BT Edelson
Trends in Immunology 2020
An inducible circular RNA circKcnt2 inhibits ILC3 activation to facilitate colitis resolution
B Liu, B Ye, X Zhu, L Yang, H Li, N Liu, P Zhu, T Lu, L He, Y Tian, Z Fan
Nature Communications 2020
Human Double-Negative Regulatory T-Cells Induce a Metabolic and Functional Switch in Effector T-Cells by Suppressing mTOR Activity
T Haug, M Aigner, MM Peuser, CD Strobl, K Hildner, D Mougiakakos, H Bruns, A Mackensen, S Völkl
Frontiers in immunology 2019
Inflammatory Cytokine Networks in Gastrointestinal Tract Graft vs. Host Disease
C Piper, WR Drobyski
Frontiers in immunology 2019
ST2/MyD88 Deficiency Protects Mice against Acute Graft-versus-Host Disease and Spares Regulatory T Cells
B Griesenauer, H Jiang, J Yang, J Zhang, AM Ramadan, J Egbosiuba, K Campa, S Paczesny
Journal of immunology (Baltimore, Md. : 1950) 2019
Donor T-cell–derived GM-CSF drives alloantigen presentation by dendritic cells in the gastrointestinal tract
KH Gartlan, M Koyama, KE Lineburg, K Chang, KS Ensbey, RD Kuns, AS Henden, LD Samson, AD Clouston, AF Lopez, KP MacDonald, GR Hill
Blood Advances 2019
Resolution of acute intestinal graft-versus-host disease
S Thiagarajan, MF Neurath, K Hildner
Seminars in Immunopathology 2019
Newly found arsons ignite the fire of gut GVHD
Defu Zeng
Journal of Clinical Investigation 2018
Targeting Inflammatory T Helper Cells via Retinoic Acid-Related Orphan Receptor Gamma t Is Ineffective to Prevent Allo-Response-Driven Colitis
V Buchele, B Abendroth, M Büttner-Herold, T Vogler, J Rothamer, S Ghimire, E Ullrich, E Holler, MF Neurath, K Hildner
Frontiers in immunology 2018

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 9 news outlets
Blogged by 2
Posted by 12 X users
On 2 Facebook pages
32 readers on Mendeley
See more details